HLA-DQ2/DQ8 inhibitors (Provid)

N/A

Report date: 2025/01/26 19:07:40
NME

Base Information

Drug NameHLA-DQ2/DQ8 inhibitors (Provid)
Drug Alias NameHLA-DQ2/DQ8 inhibitors (Provid)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionHuman leukocyte antigen inhibitors
TargetsHuman leukocyte antigen
Therapy Area/IndicationsDiabetes Mellitus, Type 1Celiac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesProvid Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Celiac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A